- Faculty
- BR1DGE
Stephen Gitelman
University of California School of Medicine, San Francisco, USA
What an exciting time in type 1 diabetes, as we better understand the underlying cause of autoimmunity, and continue to develop safe and effective means to preserve beta cells.
Stephen Gitelman is Professor of Pediatrics and Director of the Pediatric Diabetes Program at the University of California at San Francisco (UCSF). He received his undergraduate training at Princeton University, medical school training at the University of North Carolina, and completed his Pediatric residency and endocrine fellowship training at UCSF, where he has been ever since.
He holds the Mary B. Olney MD /KAK Distinguished Professorship in Pediatric Diabetes and Clinical Research. He is a clinical trialist attempting to find safe and effective means to preserve beta cell function in type 1 diabetes. He is a Clinical Center Director for the NIH sponsored consortia TrialNet; an investigator in the Immune Tolerance Network; and works closely with industry partners.
